Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-23-071900
Filing Date
2023-06-16
Accepted
2023-06-16 08:00:11
Documents
1
Group Members
DAVID ROSEN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2318906d1_sc13da.htm SC 13D/A 49350
  Complete submission text file 0001104659-23-071900.txt   50879
Mailing Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017
Business Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017 2124181881
Rubric Capital Management LP (Filed by) CIK: 0001687509 (see all company filings)

EIN.: 300934659 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Subject) CIK: 0001719714 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91444 | Film No.: 231019382
SIC: 2834 Pharmaceutical Preparations